SGK1 and breast carcinoma: SGK1 dysregulated expression was observed in hypertension, cancer, autoimmunity, and neurodegenerative disorders [16,17], and it was reported to suppress apoptosis and cellular adhesiveness in breast cancer cell lines [18,19].